Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

NCT00263601 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Grass Pollen Allergy

Interventions

BIOLOGICAL: Allergovit 6-grasses
OTHER: Placebo

Sponsor

Allergopharma GmbH & Co. KG